Skip to main content

Displaying items by tag: parkinson's

Major funding, totaling 1.49 million dollars, for pioneering research to treat Parkinson's disease, was secured from the Michael J. Fox Foundation, by the Greek-American-owned pharmaceutical company Kannalife.

Published in Diaspora